Century Therapeutics Stock (NASDAQ: IPSC) stock price, news, charts, stock research, profile.
Open | $2.53 |
Close | $2.55 |
Volume / Avg. | 3.17M / 154.25K |
Day Range | 2.42 - 2.68 |
52 Wk Range | 1.28 - 5.51 |
Market Cap | $211.25M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 2.27% |
Days to Cover | 9.94 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Century Therapeutics (NASDAQ:IPSC) through any online brokerage.
Other companies in Century Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Skye Bioscience (NASDAQ:SKYE) and Inovio Pharmaceuticals (NASDAQ:INO).
There is no analysis for Century Therapeutics.
Century Therapeutics has a consensus price target of $16.44.
The stock price for Century Therapeutics (NASDAQ: IPSC) is $2.5 last updated June 28, 2024 at 7:08 PM EDT.
There are no upcoming dividends for Century Therapeutics.
Century Therapeutics’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Century Therapeutics.
Century Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.